The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Use of GIP and GLP-1 receptor agonists in prostate cancer patients.
 
Amy Shaver
No Relationships to Disclose
 
Kevin Zarrabi
Honoraria - Curio Science; OncLive Clinical Congress Consultants
Consulting or Advisory Role - Astellas Pharma; Eisai; Exelixis; Johnson & Johnson/Janssen; Pfizer
Research Funding - Amgen (Inst); IDEAYA Biosciences (Inst); Janssen (Inst); Johnson & Johnson/Janssen (Inst); Vaccitech (Inst)
 
Nikita Nikita
No Relationships to Disclose
 
William Kelly
Honoraria - Amgen; Janssen Oncology
Consulting or Advisory Role - Amgen; Bayer; Janssen Oncology
Research Funding - Amgen (Inst); Bayer (Inst); BioClin Therapeutics (Inst); Endocyte (Inst); Exelixis (Inst); Janssen Oncology (Inst); Novartis (Inst); Regeneron (Inst); Roche (Inst); Sarah Cannon Research Institute (Inst); Seagen (Inst)
Travel, Accommodations, Expenses - Janssen Oncology
 
Grace Lu-Yao
No Relationships to Disclose